Prenetics Global Ltd

Prenetics Global Ltd is a consumer health company focused on advancing human health and longevity through science-backed products, global brand partnerships, and AI-driven operations. The company's business is organized around two brands: IM8 and CircleDNA. IM8, co-founded with David Beckham, is the flagship consumer health brand and generated $60.1 million in revenue in its first full fiscal year (FY2025), achieving $120 million in Annual Recurring Revenue (ARR) as of December 2025. IM8 ships to more than 30 countries and had a gross margin of approximately 63% in FY2025. This brand was developed to combine clinical-grade formulation with a consumer-grade brand experience. CircleDNA is a retained, complementary asset that generated $12.9 million in revenue in FY2025 with a gross margin of approximately 85%. In FY2025, Prenetics Global Ltd's total revenue from continuing operations was $92.4 million, with a gross profit of $48.8 million and a gross margin of 52.8%. The company reported a loss for the year of $(40.0) million and an Adjusted EBITDA Loss of $(13.9) million in FY2025. In Q4 2025, total revenue reached $36.6 million. IM8 operating metrics for Q4 2025 included monthly revenue of $10.0 million, quarterly revenue of $27.4 million, over 230,000 total customer orders, an average order value of $133, and a new customer subscription rate of approximately 80%.